Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Appili Therapeutics Inc
T.APLI
Alternate Symbol(s):
APLIF
Healthcare
Biotechnology
Appili Therapeutics Inc. is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help...
patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-1701, ATI-1801 and ATI-1501.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:APLI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(71)
•••
opsd1
X
Post by
opsd1
on Nov 21, 2022 1:20pm
Big bids coming in now.
What's up?
(71)
•••
opsd1
X
Post by
opsd1
on Nov 15, 2022 10:14am
APLI Secures US$14 million from US DoD for Biodefense
Appili Therapeutics ATI-1701 Biodefense Vaccine Secures ~US$14 Million of Funding from the U.S. Department of Defense in Partnership with the U.S. Air Force Academy https://stockhouse.com/news/press
...more
Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120
posted Jun 06, 2023 9:00am by
Numinus Wellness Inc.
-
|
"We're excited to support MindMed in their clinical trial work, by evaluating new important treatments and protocols to address mental health disorders...The fact that our Draper research clinic is the top enrolling site for the study underscores the quality of our clinical research capabilities and recruiting efforts ...read more
(83)
•••
bmreed
X
Post by
bmreed
on Apr 14, 2022 3:47pm
News Update w Radius Research and $APLI CEO Armand Balboni
News Update: Appili Therapeutics (APLI) w CEO Dr. Armand Balboni - Develop Leishmaniasis Treatment ATI-1801 - https://www.youtube.com/watch?v=YyE8zLvWApM {^youtubevideo|(width)425
...more
(10)
•••
ecanadian2
X
Post by
ecanadian2
on Apr 12, 2022 8:25pm
yes, lots of potential and appears to be a well run
company but: * $3.6M they raised will be used almost in full to pay off the previous loan * the interest on the new loan will be at least $1/4 million a year ... and APLI has precious little money on
...more
(83)
•••
bmreed
X
Post by
bmreed
on Apr 11, 2022 10:32am
Webinar Recap w Radius Research & $APLI CEO Armand Balboni
Webinar Recap: Appili Therapeutics (APLI) w CEO Dr. Armand Balboni - Drug Development Focused on Infectious Diseases - Pitch, Deep Dive, and Q&A - https://www.youtube.com/watch?v=xGrmHACzU7c
...more
(83)
•••
bmreed
X
Post by
bmreed
on Apr 04, 2022 10:25am
Webinar w $APLI CEO Armand Balboni Fri Apr 8 @ 12:30PM ET
Webinar - Appili Therapeutics (APLI) w/ CEO Dr. Armand Balboni Fri, Apr 8 at 12:30pm ET / 9:30am PT Q&A with Radius Research Register Here - https://us02web.zoom.us/webinar
...more
(369)
•••
Betteryear2
X
Post by
Betteryear2
on Mar 29, 2022 2:23pm
Appili Therapeutics Announces Non-Convertible Secured Loan
March 29, 2022 07:36 AM Eastern Daylight Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company
...more
(10)
•••
ecanadian2
X
Post by
ecanadian2
on Mar 16, 2022 12:37am
Will Lind be converting $3 mil into shares after Mar 18?!!
Will Lind be converting $3 million into shares after Friday March 18?! That would be 10s of millions of shares unloaded on the illiquid APLI market. Scary ... still no update from APLI on this. "
...more
Thematica Insights Report and Investor Guide
Beyond Precious
An investor's guide to precious metals and their potential in today's market. Click here to access the report.
Jocelyn Aspa
6 June 2023 09:00
(369)
•••
Betteryear2
X
Post by
Betteryear2
on Feb 28, 2022 7:58am
Over US$10 M in New Funding from US Department of Defense
February 28, 2022 07:40 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical
...more
(369)
•••
Betteryear2
X
Post by
Betteryear2
on Feb 08, 2022 7:27am
Appili Therapeutics Expands ATI-1501 Commercial Agreement
February 08, 2022 07:17 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical
...more
(16)
•••
kindvalue
X
Comment by
kindvalue
on Dec 20, 2021 2:48pm
RE:Isn't this essentially an investment banker's "house play"?
investment bankers running companies equals failure in particular BB : TMD VIV APLI MIMI ATE GTMS Oh and their great cannabis deal that was a fraud TRST
(800)
•••
SouthernTierTom
X
Post by
SouthernTierTom
on Dec 18, 2021 3:10pm
Isn't this essentially an investment banker's "house play"?
I LOVE it here! JMHO Do you own due diligence always!
(16)
•••
kindvalue
X
Post by
kindvalue
on Dec 17, 2021 2:56pm
INSIDERS
instead of insider buying they issue a stack of $0.13 warrants not a way to regain credibility companies controlled by investment bankers is not a great recipe
(369)
•••
Betteryear2
X
Post by
Betteryear2
on Nov 19, 2021 7:46am
Positive One Year Challenge Results
November 19, 2021 07:42 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company
...more
(214)
•••
mingzhu
X
Post by
mingzhu
on Nov 12, 2021 9:19pm
new drug trial coming in Dec
Preparing for ATI-2307 clinical trial drug product GMP manufacturing runs to be initiated in December 2021. https://ca.finance.yahoo.com/news/appili-therapeutics-reports-financial
...more
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Rapid Expansion of Dehydratech into USA Cannabis Markets Leads to Rapid Revenue Growth
Will 2023 be a Record-Breaking Year for Precious Metal Prices? – Experts insight available here
Full Circle Lithium Makes Significant Advancing in their Lithium Recycling Demo Plant Buildout and Related Technology